Treating and Managing Atopic Dermatitis with Matthew Zirwas, MD
February 22, 2023

Renowned dermatologist Matt Zirwas, MD, visits the Dermcast.live studio to discuss challenging atopic dermatitis patients he’s managed throughout his high-profile career in Ohio. He shares information on how he approaches patients, which issues he rules out first, and how he advises patients to manage their skin health. Dr. Zirwas and Dermcast.live host Rob Casquejo, PA-C,

New and Emerging Treatments for Atopic Dermatitis with Matthew Zirwas, MD, FAAD
December 8, 2022

Nationally recognized dermatitis specialist Dr. Matthew Zirwas reviewed atopic dermatitis (AD), highlighting new and emergent treatments for attendees at the SDPA 20th Annual Fall Dermatology Conference in Miami. He summarized the evolution of AD treatment noting “how well we can treat AD now and how bad we were at it until five years ago” due

Acne and Rosacea: Not your Mama’s Acne and Rosacea Regimens
September 17, 2022

From children to grandparents, Shanna Miranti, MPAS, PA-C, built a successful career working with a range of patients facing all severity levels of acne and rosacea. In this video, Dermcast.live host Rob Casquejo, PA-C, talks with Miranti about new therapies for acne and rosacea, and the importance of staying on the cutting edge regarding available

Everything that is New and Exciting in Pediatric Dermatology
July 1, 2022

Lisa Swanson, MD, the only practicing pediatric dermatologist in the state of Idaho, shared pearls of wisdom gained with full audience of dermatology professionals at SDPA’s summer conference in Austin, Texas. Her humor was evident as she initiated the lecture with, “Are you guys ready to be slapped in the face with pediatric dermatology?” “Early

Managing Pediatric Patients with Atopic Dermatitis; Most Patients Do Not Outgrow the Disease
June 18, 2022

  Austin physician Lucia Diaz reviewed management of atopic dermatitis (AD) with an emphasis on pediatric management. AD is the result of a skin barrier dysfunction and immune dysregulation that presents within an inflammatory loop. Up to 15% of children in the U.S. and 7% of U.S. adults suffer from AD. While the majority of